Skip to main content
Download PDF

Correction to: Platinum prodrug nanoparticles inhibiting tumor recurrence and metastasis by concurrent chemoradiotherapy

Journal of Nanobiotechnology volume 20, Article number: 234 (2022) Cite this article

The Original Article was published on 12 March 2022

Correction to: Journal of Nanobiotechnology (2022) 20:129 https://doi.org/10.1186/s12951-022–01322-y

Following publication of the original article [1], the author reported that the corresponding author symbols were omitted from the author group. Dr. Jianfeng Cai and Peipei Xu have been added to the author group and are presented correctly in this correction article. There are 3 corresponding authors, including Ms. Yong Hu (hvyong@nju.edu.cn), Jianfeng Cai (jianfengcai@usf.edu) and Peipei Xu (xu_peipei0618@163.com).

The original article [1] has been corrected.

Reference

  1. Jiang W, Wei L, Chen B, Luo X, Xu P, Cai J, Hu Y. Platinum prodrug nanoparticles inhibiting tumor recurrence and metastasis by concurrent chemoradiotherapy. J Nanobiotechnol. 2022;20:129. https://doi.org/10.1186/s12951-022-01322-y.

    Article  CAS  Google Scholar 

Download references

Author information

Author notes

  1. Wei Jiang and Lulu Wei contributed equally to this work

Authors and Affiliations

  1. Department of Hematology, Nanjing Drum Tower Hospital, Nanjing University, Nanjing, 210093, China

    Wei Jiang, Bing Chen, Xingyu Luo & Peipei Xu

  2. Institute of Materials Engineering, College of Engineering and Applied Sciences, Nanjing University, Jiangsu, 210093, China

    Wei Jiang, Xingyu Luo & Yong Hu

  3. Department of Chemistry, University of South Florida, 4202 E. Fowler Ave, Tampa, FL, 33620, USA

    Wei Jiang, Lulu Wei & Jianfeng Cai

Authors
  1. Wei Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lulu Wei
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bing Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xingyu Luo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Peipei Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jianfeng Cai
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yong Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Peipei Xu, Jianfeng Cai or Yong Hu.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jiang, W., Wei, L., Chen, B. et al. Correction to: Platinum prodrug nanoparticles inhibiting tumor recurrence and metastasis by concurrent chemoradiotherapy. J Nanobiotechnol 20, 234 (2022). https://doi.org/10.1186/s12951-022-01418-5

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12951-022-01418-5

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us